Dysregulation of astrocytic glutamate transporters, GLT-1 and GLAST, can impair astrocytic glutamate clearance and enhance glutamate accumulation which also leads to increased neuronal discharge and excitation and induction of epilepsy, which could lead to novel glial therapeutics for epilepsy (29). Here, SLC1A3 is linked to epilepsy.